These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21484871)

  • 1. Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year.
    Majid DS; Stoffers D; Sheldon S; Hamza S; Thompson WK; Goldstein J; Corey-Bloom J; Aron AR
    Mov Disord; 2011 Jul; 26(8):1481-8. PubMed ID: 21484871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
    Majid DS; Aron AR; Thompson W; Sheldon S; Hamza S; Stoffers D; Holland D; Goldstein J; Corey-Bloom J; Dale AM
    Mov Disord; 2011 Dec; 26(14):2544-51. PubMed ID: 21932302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.
    Odish OF; van den Berg-Huysmans AA; van den Bogaard SJ; Dumas EM; Hart EP; Rombouts SA; van der Grond J; Roos RA;
    Hum Brain Mapp; 2015 Jan; 36(1):110-9. PubMed ID: 25139578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
    Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
    Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive microstructural changes of the occipital cortex in Huntington's disease.
    Odish OFF; Reijntjes RHAM; van den Bogaard SJA; Roos RAC; Leemans A
    Brain Imaging Behav; 2018 Dec; 12(6):1786-1794. PubMed ID: 29492750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain structure in preclinical Huntington's disease: a multi-method approach.
    Wolf RC; Thomann PA; Thomann AK; Vasic N; Wolf ND; Landwehrmeyer GB; Orth M
    Neurodegener Dis; 2013; 12(1):13-22. PubMed ID: 22906775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.
    Wolf RC; Grön G; Sambataro F; Vasic N; Wolf ND; Thomann PA; Saft C; Landwehrmeyer GB; Orth M
    Hum Brain Mapp; 2012 Sep; 33(9):2161-73. PubMed ID: 22887827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
    Nanetti L; Contarino VE; Castaldo A; Sarro L; Bachoud-Levi AC; Giavazzi M; Frittoli S; Ciammola A; Rizzo E; Gellera C; Bruzzone MG; Taroni F; Grisoli M; Mariotti C
    Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.
    Minkova L; Gregory S; Scahill RI; Abdulkadir A; Kaller CP; Peter J; Long JD; Stout JC; Reilmann R; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
    Neuroimage Clin; 2018; 17():312-324. PubMed ID: 29527479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study.
    Odish OF; Caeyenberghs K; Hosseini H; van den Bogaard SJ; Roos RA; Leemans A
    Neuroimage Clin; 2015; 9():32-43. PubMed ID: 26288754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.
    Hobbs NZ; Henley SM; Ridgway GR; Wild EJ; Barker RA; Scahill RI; Barnes J; Fox NC; Tabrizi SJ
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):756-63. PubMed ID: 19955112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
    Scahill RI; Hobbs NZ; Say MJ; Bechtel N; Henley SM; Hyare H; Langbehn DR; Jones R; Leavitt BR; Roos RA; Durr A; Johnson H; Lehéricy S; Craufurd D; Kennard C; Hicks SL; Stout JC; Reilmann R; Tabrizi SJ;
    Hum Brain Mapp; 2013 Mar; 34(3):519-29. PubMed ID: 22102212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease.
    Wolf RC; Sambataro F; Vasic N; Wolf ND; Thomann PA; Landwehrmeyer GB; Orth M
    Exp Neurol; 2011 Oct; 231(2):214-22. PubMed ID: 21726553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpus callosal atrophy in premanifest and early Huntington's disease.
    Crawford HE; Hobbs NZ; Keogh R; Langbehn DR; Frost C; Johnson H; Landwehrmeyer B; Reilmann R; Craufurd D; Stout JC; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Scahill RI;
    J Huntingtons Dis; 2013; 2(4):517-26. PubMed ID: 25062736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease.
    Johnson EB; Rees EM; Labuschagne I; Durr A; Leavitt BR; Roos RA; Reilmann R; Johnson H; Hobbs NZ; Langbehn DR; Stout JC; Tabrizi SJ; Scahill RI;
    Neuropsychologia; 2015 Dec; 79(Pt A):138-46. PubMed ID: 26519555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.